Lexicon Pharmaceuticals (NASDAQ:LXRX) Coverage Initiated by Analysts at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) in a report issued on Wednesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on the company. Piper Sandler cut their target price on […]
Equities research analysts at StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) in a report issued on Wednesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on the company. Piper Sandler cut their target price on […]
